GoodRx Holdings, Inc. (GDRX) — Analyst outlook / Analyst consensus target is. Based on 24 analyst ratings, the consensus is bullish — 10 Buy, 13 Hold, 1 Sell.
The consensus price target is $3.19 (low: $2.75, high: $4.00), representing an upside of 43% from the current price $2.23.
Analysts estimate Earnings Per Share (EPS) of $0.34 and revenue of $0.79B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $0.04 vs est $0.34 (missed -88.3%). 2025: actual $0.09 vs est $0.36 (missed -76.3%). Analyst accuracy: 0%.
GDRX Stock — 12-Month Price Forecast
$3.19
▲ +43.05% Upside
Average Price Target
Based on 24 Wall Street analysts offering 12-month price targets for GoodRx Holdings, Inc., the average price target is $3.19, with a high forecast of $4.00, and a low forecast of $2.75.
The average price target represents a +43.05% change from the last price of $2.23.
Highest Price Target
$4.00
Average Price Target
$3.19
Lowest Price Target
$2.75
GDRX Analyst Ratings
Hold
Based on 24 analysts giving stock ratings to GoodRx Holdings, Inc. in the past 3 months
EPS Estimates — GDRX
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.04
vs Est $0.34
▼ 757.7% off
2025
Actual $0.09
vs Est $0.36
▼ 322.0% off
Profitability Outlook
Company is profitable but with thin earnings per share. EPS trend is improving. Analysts forecast meaningful EPS growth ahead.
Revenue Estimates — GDRX
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.792B
vs Est $0.794B
▼ 0.2% off
2025
Actual $0.797B
vs Est $0.795B
▲ 0.2% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
